ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,420 | -46.5% | 11,309 | -31.4% | 0.00% | – |
| Q2 2023 | $127,885 | +1093.4% | 16,480 | +776.6% | 0.00% | – |
| Q1 2023 | $10,716 | +305.1% | 1,880 | +318.7% | 0.00% | – |
| Q4 2022 | $2,645 | +32.2% | 449 | +1.1% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 444 | -15.3% | 0.00% | – |
| Q2 2022 | $2,000 | -99.8% | 524 | -99.7% | 0.00% | – |
| Q1 2022 | $953,000 | -64.4% | 178,327 | -2.1% | 0.00% | -100.0% |
| Q4 2021 | $2,677,000 | -89.4% | 182,161 | -84.9% | 0.00% | -83.3% |
| Q3 2021 | $25,276,000 | +15.1% | 1,208,792 | -2.6% | 0.01% | +20.0% |
| Q2 2021 | $21,958,000 | -25.5% | 1,241,281 | +3.1% | 0.01% | -28.6% |
| Q1 2021 | $29,491,000 | +2.0% | 1,203,741 | +41.0% | 0.01% | 0.0% |
| Q4 2020 | $28,901,000 | +85.2% | 853,806 | +36.8% | 0.01% | +75.0% |
| Q3 2020 | $15,605,000 | -19.0% | 623,936 | +9.3% | 0.00% | -33.3% |
| Q2 2020 | $19,258,000 | – | 570,961 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |